Martin Cohen
About Martin Cohen
Martin Cohen (age 76) is Chairman of the Board and a director of Cohen & Steers, Inc.; he has served as a director since August 2004 and was co-CEO/co-chairman until 2014, then Executive Chairman until retiring from the company in February 2016. He co-founded Cohen & Steers in 1986 and previously led pioneering real estate securities funds at National Securities and Research Corporation (1985) and Citibank (1980). Cohen holds a BS from City College of New York and an MBA from New York University .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Cohen & Steers, Inc. | Co-CEO & Co-Chairman | 1986–2014 | Co-founded firm; led strategy and growth; established category leadership in real assets |
| Cohen & Steers, Inc. | Executive Chairman | 2014–Feb 2016 | Oversight of Board and transition to non-executive chair |
| Cohen & Steers, Inc. | Chairman of the Board | Aug 2004–present | Chairs Board; chairs non-management executive sessions |
| National Securities & Research Corp. | Senior VP & Portfolio Manager | 1984–1986 | Organized and managed the nation’s first real estate securities mutual fund (1985) |
| Citibank | Vice President | 1976–1981 | Organized and managed the Citibank Real Estate Stock Fund (1980) |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| National Association of Real Estate Investment Trusts (NAREIT) | Board of Governors (former) | Not disclosed | Former governance role in industry association |
Board Governance
- Independence status: The Board determined Martin Cohen is not independent under NYSE standards; Messrs. Cohen, Steers, and Harvey were classified as non-independent directors as of Feb 20, 2025 .
- Committee assignments: Cohen is not listed as a member of the Audit, Compensation, or Nominating Committees; these committees are composed entirely of independent directors .
- Chair roles: He serves as non-executive Chairman of the Board and chairs executive sessions of non-management directors; executive sessions of only independent directors are chaired on a rotational basis by an independent director .
- Board leadership structure: CNS separates the Chairman and CEO roles (since 2014) and does not have a lead independent director; the Board and Nominating Committee believe a lead independent is unnecessary given the majority-independent composition and governance processes .
- Attendance and engagement:
- Meetings held in 2024: Board (6), Audit (8), Compensation (3), Nominating (3) .
- Attendance: Each director attended at least 75% of meetings of the Board and committees on which they served; all directors serving at the time attended the 2024 annual meeting .
| Body | Meetings in 2024 | Attendance disclosure |
|---|---|---|
| Board of Directors | 6 | Each director ≥75% |
| Audit Committee | 8 | Each director ≥75% |
| Compensation Committee | 3 | Each director ≥75% |
| Nominating Committee | 3 | Each director ≥75% |
Fixed Compensation
- Structure for non-management directors: Annual retainer $210,000 ($100,000 cash; $110,000 RSUs, granted quarterly, 100% vested at grant, delivered in three years; dividends paid in cash); additional retainers: Chairman of the Board $180,000 cash; Audit Chair $15,000; Compensation Chair $7,500; Nominating Chair $5,000; Audit Committee members $15,000; Compensation Committee members $7,500; Nominating Committee members $5,000 (quarterly in arrears) .
- Co-investment opportunity: Directors/officers may co-invest in certain company-advised vehicles without management fees or carried interest .
| 2024 Director Compensation (Cohen) | Amount ($) |
|---|---|
| Fees Earned or Paid in Cash | 280,167 |
| Stock Awards (RSUs, grant-date fair value) | 109,860 |
| All Other Compensation (medical/dental employer portion per employment agreement) | 23,701 |
| Total | 413,728 |
Performance Compensation
- Non-management director compensation is not performance-based; RSUs are fully vested at grant and delivered after three years; dividends on common stock are paid in cash to non-management directors .
- Quarterly RSU grant detail for 2024 (Cohen):
| Grant Date | RSUs Granted | Grant-Date Fair Value ($) | Vesting | Delivery |
|---|---|---|---|---|
| Jan 2, 2024 | 365 | 27,467 | 100% vested at grant | Delivered on third anniversary |
| Apr 1, 2024 | 362 | 27,454 | 100% vested at grant | Delivered on third anniversary |
| Jul 1, 2024 | 383 | 27,482 | 100% vested at grant | Delivered on third anniversary |
| Oct 1, 2024 | 291 | 27,457 | 100% vested at grant | Delivered on third anniversary |
Other Directorships & Interlocks
- Current public company boards: None disclosed for Martin Cohen beyond CNS .
- Interlocks/related roles: Not disclosed; Board independence determination noted some directors are or are considering becoming investors in company-managed funds; Board did not deem this material .
Expertise & Qualifications
- Real assets and listed real estate pioneer; co-founded specialized asset manager in 1986 .
- Track record launching first real estate securities mutual fund (1985) and Citibank Real Estate Stock Fund (1980) .
- Education: BS (City College of New York), MBA (NYU) .
- Industry governance: Former NAREIT Board of Governors .
Equity Ownership
- Cohen is a significant shareholder and 10% beneficial owner; his ownership provides strong alignment but also concentrated influence over outcomes requiring shareholder approval .
| Holder | Shares Beneficially Owned | % of Outstanding | RSUs Held | Notable Ownership Details |
|---|---|---|---|---|
| Martin Cohen | 9,015,216 | 17.8% | 4,326 | Includes 8,171,461 shares in the Martin Cohen 2018 Revocable Trust; 315 shares to be delivered on Apr 1, 2025 upon RSU settlement |
- Company policy: Directors and employees are prohibited from hedging company securities; the proxy notes individuals may hold shares in accounts with a margin feature, but no pledging is disclosed; the company does not maintain formal director/executive stock ownership guidelines, citing meaningful collective ownership .
Insider Trades (recent)
| Date | Filing | Link | Notes |
|---|---|---|---|
| Apr 2, 2025 | Form 4 | https://www.sec.gov/Archives/edgar/data/1284812/000128481225000146/0001284812-25-000146-index.htm | Reporting person: COHEN MARTIN (changes in beneficial ownership) |
| Nov 13, 2024 | Form 4 | https://www.sec.gov/Archives/edgar/data/1284812/000128481224000366/0001284812-24-000366-index.htm | Changes in beneficial ownership (trust-related holdings referenced by third-party summaries) |
| Aug 28, 2024 | Form 4 | http://pdf.secdatabase.com/1438/0001284812-24-000320.pdf | Reporting date Aug 27, 2024 (Revocable Trust referenced in summaries) |
| Jul 2, 2024 | Form 4 | http://pdf.secdatabase.com/1375/0001284812-24-000257.pdf | Reporting date Jul 1, 2024; shares held by the Martin Cohen 2018 Revocable Trust (per explanation) |
Governance Assessment
-
Strengths
- Founder with deep domain expertise and long-tenured leadership in real assets; valuable strategic and historical knowledge for Board oversight .
- Clear separation of Chair and CEO roles; structured committee system with fully independent membership; regular executive sessions of independent directors .
- Robust insider trading and hedging prohibitions; formal clawback policy adopted for incentive compensation (executives) per SEC/NYSE rules .
-
Concerns and potential red flags
- Concentrated ownership and control: Cohen beneficially owns 17.8% of outstanding shares; combined founder holdings (Cohen and Steers) confer meaningful influence over director elections and shareholder approvals, potentially reducing minority shareholder power .
- Independence optics: Chairman is not independent; Board lacks a lead independent director; Cohen chairs non-management executive sessions, which may limit purely independent oversight dynamics .
- Related-party/perquisite exposure: Continued employer-paid portion of medical/dental coverage under a prior employment agreement is unusual for non-management directors; modest in size but notable for governance optics .
- Co-investment arrangements: Directors/officers may co-invest in company-managed vehicles without fees/carry; while customary in asset management, it warrants monitoring for potential conflicts in fund oversight decisions .
- Ownership guidelines: Absence of formal stock ownership guidelines for directors/executives (despite high insider ownership) may reduce codified alignment standards, though practical alignment is strong .
-
Attendance/Engagement: 2024 attendance exceeded 75% for all directors; Cohen’s role includes chairing executive sessions and Board leadership, indicating active engagement .
Other Notes and Policies
- Related party transactions policy requires Audit Committee or disinterested independent approval for Item 404(a) transactions over $120,000; routine client/product transactions at market terms are exempt .
- Board diversity disclosure and ongoing governance guideline review suggest attention to board composition and oversight processes .
Overall, Cohen’s founder experience and significant ownership provide alignment and continuity but present independence and concentration risks. The lack of a lead independent director and ongoing perquisite coverage are governance signals to monitor, alongside any future related-party transactions or changes in committee structures .